Flotufolastat F-18 Gallium Patent Expiration
Flotufolastat F-18 Gallium is used for imaging prostate cancer recurrence. It was first introduced by Blue Earth Diagnostics Ltd
Flotufolastat F-18 Gallium Patents
Given below is the list of patents protecting Flotufolastat F-18 Gallium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Posluma | US12036290 | Pharmaceutical formulations | Nov 27, 2041 | Blue Earth |
| Posluma | US11413360 | Dual mode radiotracer and—therapeutics | Nov 22, 2038 | Blue Earth |
Flotufolastat F-18 Gallium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List